ViraTherapeuticsis a spin-off company from the Medical University in Innsbruck (Austria). The company develops highly potent anti-cancer therapeutics based on oncolytic (cancer destroying) viruses. Our proprietary oncolytic virus, VSV-GP, efficiently destroys cancer cells, while leaving normal tissues unharmed. VSV-GP is the only oncolytic virus that is effective upon repeated application and thus, has the potential to cure
